Literature DB >> 21873315

Production of ELOVL4 transgenic pigs: a large animal model for Stargardt-like macular degeneration.

Jeffrey R Sommer1, Jose L Estrada, Edwin B Collins, Matthew Bedell, Curtis A Alexander, Zhenglin Yang, Guy Hughes, Bashir Mir, Brian C Gilger, Seanna Grob, Xinran Wei, Jorge A Piedrahita, Peter X Shaw, Robert M Petters, Kang Zhang.   

Abstract

BACKGROUND: Truncation mutations in the elongation of very long chain fatty acids-4 (AF277094, MIM #605512) (ELOVL4) gene cause Stargardt-like macular dystrophy type 3 (STGD3). Mice expressing truncated ELOVL4 develop rapid retinal degeneration, but are poor STGD3 models since mice lack a macula. Photoreceptor topography in the pig retina is more similar to that in humans as it includes the cone rich, macula-like area centralis. The authors generated transgenic pigs expressing human disease-causing ELOVL4 mutations to better model the pathobiology of this macular disease.
METHODS: Pronuclear DNA microinjection and somatic cell nuclear transfer were used to produce transgenic pigs for two different ELOVL4 mutations: the 5 base pair deletion (5 bpdel) and the 270 stop mutation (Y270terEYFP). Retinal transgene expression, morphology and electrophysiology were examined.
RESULTS: The authors obtained four lines of Y270terEYFP and one line of 5 bpdel transgenic animals. Direct fluorescence microscopy indicated that the Y270terEYFP protein is expressed in photoreceptors and mislocalised within the cell. Immunohistochemical examination of transgenic pigs showed photoreceptor loss and disorganised inner and outer segments. Electroretinography demonstrated diminished responses in both transgenic models.
CONCLUSIONS: These transgenic pigs provide unique animal models for examining macular degeneration and STGD3 pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21873315     DOI: 10.1136/bjophthalmol-2011-300417

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  27 in total

Review 1.  Genetically engineered livestock for biomedical models.

Authors:  Christopher S Rogers
Journal:  Transgenic Res       Date:  2016-01-28       Impact factor: 2.788

Review 2.  Genome editing revolutionize the creation of genetically modified pigs for modeling human diseases.

Authors:  Jing Yao; Jiaojiao Huang; Jianguo Zhao
Journal:  Hum Genet       Date:  2016-07-18       Impact factor: 4.132

3.  ELOVL4-Mediated Production of Very Long-Chain Ceramides Stabilizes Tight Junctions and Prevents Diabetes-Induced Retinal Vascular Permeability.

Authors:  Nermin M Kady; Xuwen Liu; Todd A Lydic; Meesum H Syed; Svetlana Navitskaya; Qi Wang; Sandra S Hammer; Sandra O'Reilly; Chao Huang; Sergey S Seregin; Andrea Amalfitano; Vince A Chiodo; Sanford L Boye; William W Hauswirth; David A Antonetti; Julia V Busik
Journal:  Diabetes       Date:  2018-01-23       Impact factor: 9.461

4.  A detailed three-step protocol for live imaging of intracellular traffic in polarized primary porcine RPE monolayers.

Authors:  Kimberly A Toops; Li Xuan Tan; Aparna Lakkaraju
Journal:  Exp Eye Res       Date:  2014-05-23       Impact factor: 3.467

5.  Defective phagosome motility and degradation in cell nonautonomous RPE pathogenesis of a dominant macular degeneration.

Authors:  Julian Esteve-Rudd; Roni A Hazim; Tanja Diemer; Antonio E Paniagua; Stefanie Volland; Ankita Umapathy; David S Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-07       Impact factor: 11.205

Review 6.  Genetically modified pigs for biomedical research.

Authors:  Yonglun Luo; Lin Lin; Lars Bolund; Thomas G Jensen; Charlotte Brandt Sørensen
Journal:  J Inherit Metab Dis       Date:  2012-03-28       Impact factor: 4.982

7.  Rise of the Pigs: Utilization of the Porcine Model to Study Musculoskeletal Biomechanics and Tissue Engineering During Skeletal Growth.

Authors:  Stephanie G Cone; Paul B Warren; Matthew B Fisher
Journal:  Tissue Eng Part C Methods       Date:  2017-09-01       Impact factor: 3.056

Review 8.  Genetically modified pigs to model human diseases.

Authors:  Tatiana Flisikowska; Alexander Kind; Angelika Schnieke
Journal:  J Appl Genet       Date:  2014-02       Impact factor: 3.240

9.  Deciphering mutant ELOVL4 activity in autosomal-dominant Stargardt macular dystrophy.

Authors:  Sreemathi Logan; Martin-Paul Agbaga; Michael D Chan; Nabila Kabir; Nawajes A Mandal; Richard S Brush; Robert E Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-18       Impact factor: 11.205

Review 10.  Precision editing of large animal genomes.

Authors:  Wenfang Spring Tan; Daniel F Carlson; Mark W Walton; Scott C Fahrenkrug; Perry B Hackett
Journal:  Adv Genet       Date:  2012       Impact factor: 1.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.